TGFB2 and adenomyosis: To determine whether organoids are a suitable in vitro model of the in vivo pathological features of adenomyosis, TGF-β2 and SMAD3 expression were evaluated by IHC in Control and Adeno (n = 6/group) sec- and gest-organoids.